Vice President Corporate Business Development

Immix Biopharma (Nasdaq: IMMX); Los Angeles (CA); On-site; USD 180,000 - 260,000; Full time

Job summary

Immix Biopharma, Inc. seeks a Vice President of Corporate & Business Development to establish and nurture strategic partnerships with pharma and biotech companies.

You will source opportunities, conduct rigorous business evaluations, and build robust financial models to value projects. You will lead external engagement in the biotech community, present analyses to senior leadership, and represent the company at industry conferences.

Qualifications

• 5-10 years of biopharma/pharmaceutical experience.
• Established track record of successful strategic transactions in biopharma.
• Strong knowledge of biotechnology/pharmaceutical industry, drug discovery and development.
• Excellent verbal and written communication skills; strong relationship management.

Responsibilities

• Establish and maintain relationships with pharma/biotech companies to identify partners.
• Source and track opportunities aligned with corporate goals.
• Lead analysis and provide financial and strategic evaluation of BD opportunities.
• Develop and present financial models and market analyses for projects.
• Act as external liaison to raise awareness of partnering capabilities.

Skills

Biopharma experience

Strategic transactions

Financial modeling

Industry knowledge

Communication skills

Cross-functional work

Education

Bachelor's degree or higher in biology/finance

Job description

Vice President Corporate & Business Development

Our 3 Core Values

• Integrity
• Initiative

What You'll Do

• Establish and maintain strong relationships with pharmaceutical and biotech companies; identify potential strategic corporate development and business partners
• Source, screen and track business opportunities that are aligned with corporate goals and objectives by interacting with biotech, and pharma counterparts
• Lead information research and provide robust analytic and business evaluation support of corporate and business development opportunities, potential company strategies, and key business initiatives
• Develop and present robust financial models and market analyses to value projects
• Visible external liaison in the scientific and biotech communities to raise awareness of company’s partnering objectives and capabilities
• Attend strategic partnering and industry conferences related to therapeutic area of interest
• Monitor and advise the Company’s leadership on competitive intelligence and relevant developments in key indications and therapeutic areas of interest

Skills and Experience We Look For

• Bachelor’s degree or higher in biology, finance or related field with 5-10 years’ biopharma/pharmaceutical experience
• Established track record of successful strategic transactions in the biopharmaceutical industry
• Strong knowledge of biotechnology/pharmaceutical industry, drug discovery and development
• Excellent verbal and written communication skills, strong relationship management skills and strategic thinking
• Proven experience successfully supporting the scientific and business evaluation of technologies, assets, or companies in the biotechnology/pharmaceutical industry
• Demonstrated understanding of pharmaceutical product lifecycle management including drug development, FDA regulations, and commercialization paths
• Outstanding organizational, analytical, interpersonal and communication skills
• Adaptability, flexibility, and willingness to work in a changing environment
• Experience with financial analysis and/ or valuation of biopharmaceutical products and companies and advanced excel/modeling skills required
• A collaborative nature with the knowledge and understanding of the role and importance of working cross-functionally
• Self-starter, highly motivated, results-driven individual; ability to creatively solve problems
• Process-minded with the ability to operate strategically and adapt when appropriate to execute on defined goals in a timely manner
• Experience preparing and delivering presentations to senior management
• Familiarity with biopharma / pharmaceutical portfolio strategy and competitive dynamics

About Immix Biopharma, Inc.

Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a global leader in AL Amyloidosis. AL Amyloidosis is a devastating disease where the immune system, that's supposed to protect, instead produces toxic light chains, clogging up the heart, kidney and liver, causing organ failure and death. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201 with a "digital filter" that is designed to filter out non-specific activation. NXC-201 teaches the immune system to recognize and eliminate the source of the toxic light chains. NXC-201 is being evaluated in the U.S. multi-center study for relapsed/refractory AL Amyloidosis NEXICART-2 (NCT06097832), with a potentially registrational design. NXC-201 has been awarded Breakthrough Therapy Designation (BTD) and Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by FDA and in the EU by the EMA.